Skip to content
etf.net

Launched · SEC filings

ROBO Global Healthcare Technology and Innovation ETF

HTECNYSE ArcaROBO GlobalC

$45.27−0.23 (−0.51%)

At close: Nov 2, 2026, 4:00 PM ET

C40/ 100

Rank 16 of 25 in Health Care (Broad)

C40/100Rank 16 of 25inHealth Care (Broad)
Intraday session: down, 79 prints from 45.50 to 45.27. Range 45.21 to 45.83. Use the arrow keys to read each point.45.2045.4045.6045.7045.8010 AM12 PM2 PM4 PM
Expense ratio
0.68%*
Fund size
$115M
1Y total return
+37.1%
Yield · Last 12 months
0.76%
Holdings
62
Avg volume · 30D
47.2K sh
52W range
low $31.84high $46.56
Launched
Filings
SEC EDGAR

*After a fee waiver that ends Aug 31, 2027. Without it: 0.80%.

The ETF.net HTEC Grade

Based on 5 of 6 pillars

C

Score 40 out of 100

Category
Health Care (Broad)⁠
Rank
16 of 25
Six-pillar profile for HTEC. Scores out of 100: Cost 21, Risk 57, Mission not scored, Tradability 34, Holdings 84, Durability 47. Strongest: Holdings (84). Weakest: Cost (21). Based on 5 of 6 pillars.

Score 40 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    F21 out of 100
    Rank 20 of 25

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B57 out of 100
    Rank 10 of 25

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    D34 out of 100
    Rank 17 of 25

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    A84 out of 100
    Rank 4 of 25

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    C47 out of 100
    Rank 16 of 25

Our read on HTEC

ETF.net Research

In short

CBroad healthcare ETFs are mostly big pharma in a trench coat. HTEC goes the other way: roughly 60 global companies building the tools, from robotic surgery to gene sequencing to AI-assisted diagnostics.

Stated mandate

The Fund seeks to track the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index before fees and expenses. It uses a primarily passive strategy and normally invests at least 80% of assets in Index or Healthcare Technology Company securities.

Why people hold it

  • Theme first, pharma second. The index screens for firms drawing a real portion of business and revenue from healthcare technology, so you own tool builders, not drugmakers.sec.gov
  • Roughly 60 names spread across the healthcare-tech value chain, from diagnostics to robotic surgery, so no single stock runs the show.vettafi.com
  • Global by construction: the index is built as a worldwide benchmark, not a US-only one, so device and genomics firms listed abroad are in scope.vettafi.com
  • Trading since 2019, so there is a real operating history behind the theme rather than a back-test and a brochure.

Worth knowing

  • You pay up for the specialty: 0.68% net of a waiver through August 31, 2027 (0.80% gross), versus 0.08% for XLV and 0.09% for VHT, and above the category norm.
  • A smaller, thinly traded fund, so bid-ask spreads can run wider than the giant healthcare trackers and sizable orders may take patience.
  • Narrow by design. Roughly 60 innovation names can swing harder than a broad healthcare index, and most big pharma simply is not in the basket.

HTEC Performance

Launched Jun 25, 2019

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.
HTEC$13,706
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. HTEC $13,706. SPY $11,199. Use the arrow keys to read each point.$10,000$12,000$14,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for HTEC. Periods over one year show the average yearly return.
PeriodHTEC
Year to date+28.8%
1 month+2.6%
3 months+18.3%
1 year+37.1%
3 yearsper year+27.0%
5 yearsper year−0.3%
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for HTEC
YearReturn barHTEC
2026 YTD+28.8%
2025+23.9%

HTEC in the news

HTEC Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
0.76%Last 12 months
Payout per share
$0.35Last 12 months
Last payment
$0.35 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Irregular

Distribution history

2021–2026

One bar per payment. 2 payments from 2021 to 2026 YTD. Dec 28, 2021 $0.02; Dec 30, 2025 $0.35. Use the arrow keys to read each point.202120222023202420252026YTD
Ex-datePay dateAmount per share
Dec 30, 2025Dec 31, 2025$0.35
Dec 28, 2021Dec 31, 2021$0.02

$10,000 in HTEC 5 years ago paid $78.38 in dividends.

HTEC Risk

Risk pillarB57 out of 100Rank 10 of 25 in Health Care (Broad)
How much the fund’s monthly returns vary, scaled to a year.
18.8%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
1.14
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−54.7%
Trough Oct 2023
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
1.23
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

HTEC Cost

Compare HTEC and XLV

Overpaying vs XLV, cheapest in Health Care (Broad)

$11,563

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • HTEC 0.68%

    $13,252

  • XLV 0.08% Cheapest

    $1,689

$10,000
30 years

Cost over time

  • HTEC 0.68%
  • XLV 0.08%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K051015202530HTEC $13,252XLV $1,689

Year by year

YearHTECXLVOverpaying
10$1,215$147$1,068
20$4,633$575$4,058
30$13,252$1,689$11,563
How the 0.68% is worked out

Full fee 0.80%− waiver 0.12%= you pay 0.68%

The waiver ends Aug 31, 2027. After that the fee is 0.80% unless ROBO Global renews it. Source: prospectus, Aug 2026.

Other funds in Health Care (Broad)

See others